79
61
Growth Score 79 in past quarter
-8 pts
Heat Score 61 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1264325
Granalix is a biotech company developing innovative formulations of natural compounds that increase their bioavailability.
- Ruth Gabizon: Scientific Director and Co-Founder
About the Company
Granalix is a biotech company developing innovative formulations of natural compounds that increase their bioavailability. The company's first product, GranaGard, is a submicron self-emulsion formulation of pomegranate seed oil, which contains high concentrations of punicic acid (PA), one of the strongest natural antioxidants. In the GranaGard
formulation, PA has been shown to convert in vivo into conjugated linoleic acid, an established neuroprotector, and mitochondrial activity modulator.
Granalix was founded in 2013 and is headquartered in Jerusalem, Israel.